Stay updated on Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.

Latest updates to the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRemoved references to Interstitial lung disease 2 and the Genetic and Rare Diseases Information Center under Resources.SummaryDifference0.2%

- Check17 days agoChange Detected- Revision updated to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check24 days agoChange DetectedFooter now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision history updated: added Revision: v3.4.2 and removed Revision: v3.4.1. This is a minor metadata update to the page.SummaryDifference0.1%

- Check60 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing Revision: v3.4.0.SummaryDifference0.1%

- Check67 days agoChange DetectedGlossary visibility was added, and the page now displays a 'Last Update Submitted that Met QC Criteria' indicator along with a 'No FEAR Act Data' label and a revision note 'v3.4.0'. The previous phrasing 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' plus revision 'v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Blood Levels of IDL-2965 in Pulmonary Fibrosis Clinical Trial page.